Trial · NCT07428369
A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)
NCT07428369, Phase 2, Phase 3, Withdrawn, Regeneron Pharmaceuticals
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM). Trials, record NCT07428369. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07428369
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)
- NCT number
- NCT07428369
- Status
- Withdrawn
- Phases
- Phase 2, Phase 3
- Enrollment
- 0 participants, actual
- Lead sponsor
- Regeneron Pharmaceuticals
- Conditions
- Multiple Myeloma (MM)
- Interventions
- Linvoseltamab, Bortezomib, Lenalidomide, Daratumumab, Dexamethasone
- First posted
- 2026-02-23
- Last updated
- 2026-06-18
Source ClinicalTrials.gov
Registered outcomes74
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Occurrence of Treatment-Emergent Adverse Events (TEAEs) | Up to day 112 | Phase 2 |
| Primary | Severity of TEAEs | Up to day 112 | Phase 2 |
| Primary | Achievement of Complete Response or better (≥CR) per International Myeloma Working Group (IMWG) criteria | Up to day 112 | Phase 2 |
| Primary | Minimal Residual Disease (MRD) negative CR at 10^-5 per IMWG criteria | Up to 12 months | Phase 3 |
| Primary | Progression Free Survival (PFS) per IMWG | Up to 5 years | Phase 3 |
| Secondary | Occurrence of TEAEs | Up to 3.5 years | Phase 2 |
| Secondary | Severity of TEAEs | Up to 3.5 years | Phase 2 |
| Secondary | Occurrence of Serious Adverse Events (SAEs) | Up to 3.5 years | Phase 2 |
| Secondary | Severity of SAEs | Up to 3.5 years | Phase 2 |
| Secondary | Occurrence of Cytokine Release Syndrome (CRS) | Up to day 30 | Phase 2 |
1 to 10 of 74Source ClinicalTrials.gov
See all 74 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07428369
GET https://conductscience.org/api/trials/v1/NCT07428369/registered?page=2